Notable Labs (NTBL) has released an update.
Notable Labs, Ltd. has announced an update on their Phase 2 clinical trial for the drug volasertib, promising to bring potential advancements in treatment to the forefront of medical and investor communities.
For further insights into NTBL stock, check out TipRanks’ Stock Analysis page.
